Description

1-(4-Chlorophenyl)-n-(3-Cyano-4,5,6,7-Tetrahydro-1-Benzothien-2-Yl)-4-Oxo-1,4-Dihydro-3-Pyridazinecarboxamide is a high-purity, advanced pharmaceutical intermediate designed for the synthesis of novel active pharmaceutical ingredients (APIs). This compound matters for its role as a critical building block in medicinal chemistry research and development, enabling the creation of targeted therapeutic agents. It is primarily needed by pharmaceutical R&D laboratories, contract research organizations (CROs), and fine chemical manufacturers focused on developing new drugs, particularly in areas requiring complex heterocyclic scaffolds.

Application

• Pharmaceutical Intermediate: Serves as a key precursor in the synthesis of novel drug candidates targeting various disease pathways.
• Medicinal Chemistry Research: Used in structure-activity relationship (SAR) studies and lead optimization processes in drug discovery.
• API Development: Employed in the development and scale-up processes for new active pharmaceutical ingredients.
• Biochemical Research: Acts as a tool compound for probing biological mechanisms and enzyme interactions in vitro.
• Custom Synthesis: A starting material for the contract manufacturing of specialized, high-value fine chemicals.

Basic Information

Product Name	1-(4-Chlorophenyl)-n-(3-Cyano-4,5,6,7-Tetrahydro-1-Benzothien-2-Yl)-4-Oxo-1,4-Dihydro-3-Pyridazinecarboxamide
CAS No.	898515-59-8
Molecular Formula	C20H15ClN4O2S
Molecular Weight	410.88 g/mol
Synonyms	1-(4-Chlorophenyl)-N-(3-cyano-4,5,6,7-tetrahydro-1-benzothiophen-2-yl)-4-oxo-1,4-dihydropyridazine-3-carboxamide; 898515-59-8; 1-(4-Chlorophenyl)-N-(3-cyano-4,5,6,7-tetrahydrobenzo[b]thiophen-2-yl)-4-oxo-1,4-dihydropyridazine-3-carboxamide; Pyridazinecarboxamide, 1-(4-chlorophenyl)-N-(3-cyano-4,5,6,7-tetrahydro-1-benzothien-2-yl)-4-oxo-1,4-dihydro-
EINECS	Contact for details

Quality Control

Our 1-(4-Chlorophenyl)-n-(3-Cyano-4,5,6,7-Tetrahydro-1-Benzothien-2-Yl)-4-Oxo-1,4-Dihydro-3-Pyridazinecarboxamide is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation via spectroscopic methods, to ensure compliance with exacting standards for pharmaceutical intermediates. Certificates of Analysis (COA) detailing batch-specific results are available upon request.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at controlled room temperature (typically 15-25°C). Keep away from incompatible materials. For long-term storage, consider inert atmosphere conditions to maintain product integrity.

Specification

Item	Specification
Appearance	Off-white to light yellow powder
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 97.0%
Loss on Drying	≤ 1.0%
Residue on Ignition	≤ 0.5%
Heavy Metals	≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.